Clinical Trial Update: High-dose Selenium Supplementation in Patients With Left Ventricular Assist [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating high-dose selenium supplementation in patients with left ventricular dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Dysfunction

Drugs mentioned

• selenium (high-dose supplementation) (selenium)

Snippet

Sponsor: RWTH Aachen University | Conditions: Ventricular Dysfunction, Left | Phase 3 | Status: COMPLETED